AI assistant
Sending…
RESMED INC — Director's Dealing 2019
Feb 19, 2019
30071_dirs_2019-02-19_58630234-dacc-4c49-9d5d-03104adece7f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-02-15
Reporting Person: Hollingshead James (President, Americas)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-15 | ResMed Common Stock | F | 832 | $100.45 | Disposed | 81257 | Direct |
Footnotes
F1: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 2/16/2017.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29